
Jessica Strzepka
@GIJessMD
Followers
87
Following
116
Media
7
Statuses
22
GI fellow @Rush_GI | @RushDOIM | @uiccom ‘20 | @Illinois_Alumni ‘16
Chicago, IL
Joined May 2022
So much fun at my first DDW! Grateful for the opportunity to share my research and learn from leaders in the field. Looking forward to next year already! @DDWMeeting @AmerGastroAssn @RushMedical @RushDOIM
0
2
6
Thank you to the Cook County GI fellowship program for inviting @Rush_GI to attend their @AmCollegeGastro visiting professorship with @RenaYadlapati of @UCSD_GI! . Such a fun & educational day learning all things esophageal motility from a leader in the field!👏🏻. @CookCountyIMR
1
4
39
Such an inspiring WHISE leadership forum today at @CLDFoundation’s 4th annual Liver Connect conference! Perfect end to a great conference weekend! @NancyReau
0
1
2
Great time working with Community Empowerment in the Dominican Republic this past week! @RushMedical @RushDOIM
0
0
7
Hep B/C in women/🤰@TatyanaKushner WHO 🌎 health strat (‘22-‘23): goal to ⬆️ vax, dec vertical transmission (⬆️ risk with ⬆️ viral load, HCV/HIV coinfxn, ⬇️access/knowledge/policies). ⬆️ data for HCV tx in 🤰upcoming. 4.5 mil HBV and 0.1-4.1% HCV births annually (⬆️ w geo/IVDU).
0
1
2
Pregnancy Guidelines by @AniKardashianMD ➡️intrahepatic cholestasis of pregnancy: most common gestational 🤰liver disease. Universal HCV screening guidelines= ⬆️ ➕ rates (need more antiviral tx safety data in preg). ASA ppx for preeclampsia🟰variable recs/data.
1
0
1
🤰& portal HTN by @NancyReau: ⬆️ rates of chronic liver disease in women of childbearing age (10➡️25%). Fertility NOT affected in compensated cirrhosis pts. ⬆️ risk preeclampsia/preterm birth. AASLD: EV screen (18-20% maternal mortality) 12 mos preconception (NSBB OK in 🤰).
1
0
1
PBC/AIH in minority women by @lilydaramd: early studies DON’T look at race/ethnicity➡️modern era w/⬆️ awareness. AIH: black pts present younger w/ more adv fibrosis. PBC: Latinx pts present at adv stages w/ more variant/overlap dz. Need: ⬆️ access to care, diversity of care team.
2
1
2
Sex diff & drug research/development by @TramTran_MD: ➡️decades of work to incorporate females into trials ➡️consider pharm metabolism differences between sexes ➡️CV research as model for studying sex diff ➡️liver accounts for expression of 72% of sexually differentiated genes.
1
0
0
So excited to be attending the CLDF Liver Connect conference in Huntington Beach, CA and seeing the WHISE (Women in Hepatology, Initiatives, Sponsorship & Empowerment) “Filling the gender gaps in liver disease” session come together!👇 highlights from our speakers @CLDFoundation.
1
0
8
RT @NancyReau: 🚨We are now accepting abstract submissions for #RushIntoGI: An Update in Gastroenterology & Hepatology 🚨. 🔹Submission Deadli….
0
1
0
RT @ManaviBhagwat: Thanks to @RushDOIM PGY-3 @JessStrzepkaMD for this great talk on PPI use in cirrhosis! Long term PPI use assoc. w/ incre….
0
2
0
Great first day at #ACG2022 enjoying the postgraduate course! @ManaviBhagwat @BSchwartzMD @TaviaBuysseMD @AmCollegeGastro @RushDOIM @RushIMChiefs
0
3
17
Congratulations to @plrabin for an excellent oral presentation on our POCUS course research at #CHEST2022 Excited for the first session of this year’s course in our SIM center today! @Rushpulmcc @RushDOIM @RushIMChiefs @accpchest
0
3
10
RT @NancyReau: 🎈 Congratulations to @JessStrzepkaMD of @RushDOIM on a fantastic poster for the #DeltaCure Meeting!🎈. #livertwitter https:….
0
2
0
An incredible experience and opportunity to attend and present at the first annual #DeltaCure conference! With an excellent presentation by @NancyReau on the epidemiology of #HDV in North America. So great to hear and learn from experts around the 🌎! @RushDOIM @RushMedical
0
0
8